Contact us for a free legal consultation about your Heparin Recall Lawsuit
Baxter's Multiple-dose Vial Heparin Linked to Severe Allergic Reactions
The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high bolus doses of the drug.
Baxter Healthcare Issues Urgent Nationwide Heparin Multi-Dose Vial Recall
Baxter Healthcare Corporation has announced the voluntary recall of nine lots of heparin sodium injection 1000 units/mL 10mL and 30mL multi-dose vials. The company began recalling the lots on January 17, 2008 as a precautionary measure due to an increase in the number of reports of adverse patient reactions that may be associated with the product.
National Kidney & Urologic Disease Information Clearinghouse
This site has everything from A to Z regarding kidneys and kidney health with a large section explaining dialysis, specifically hemodialysis and how it relates to the blood.
Verdicts & Settlements |
Anapol TV |
Our Attorneys |
About Us |
Contact Us |
Site Map
Philadelphia, PA - Cherry Hill, NJ - Media, PA - Reading, PA - Harrisburg, PA
Copyright © - Anapol Schwartz - Pennsylvania Heparin Recall Attorneys - Philadelphia Heparin Recall Law Firm. All rights reserved.
Philadelphia Heparin Recall Attorney Disclaimer: This website is dedicated to providing public information regarding Heparin Recall and other legal information. None of the information on this site is intended to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Central Pennsylvania personal injury lawyer or New Jersey Heparin recall attorney at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey and Pennsylvania.